These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 286603)

  • 1. The relationship of cytosine arabinoside phosphorylation to inhibition of DNA synthesis in human leukaemic myeloblasts [proceedings].
    Harris AL
    Br J Clin Pharmacol; 1979 Apr; 7(4):424P-425P. PubMed ID: 286603
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
    Harris AL; Grahame-Smith DG; Potter CG; Bunch C
    Clin Sci (Lond); 1981 Feb; 60(2):191-8. PubMed ID: 6940687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cytosine arabinoside on nuclear labelling of leukaemic myeloblasts with tritiated thymidine triphosphate.
    Waetzin GL
    Leuk Res; 1979; 3(1):7-13. PubMed ID: 294488
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
    Epstein J; Preisler H
    Eur J Cancer (1965); 1981 Jun; 17(6):623-8. PubMed ID: 6946929
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
    Potter CG; Bunch C
    Br J Cancer; 1980 Jun; 41(6):985-8. PubMed ID: 6932908
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
    Wantzin GL; Karle H; Killmann SA
    Br J Haematol; 1976 Feb; 32(2):283-9. PubMed ID: 1061618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in sensitivity of DNA synthesis to ara-C in acute myeloid leukaemia.
    Harris AL; Grahame-Smith DG
    Br J Haematol; 1980 Jul; 45(3):371-9. PubMed ID: 6932952
    [No Abstract]   [Full Text] [Related]  

  • 8. Coordinated changes in biochemical patterns: the effect of cytosine arabinoside and methotrexate on leukocytes from patients with acute granulocytic leukemia.
    Roberts D; Hall TC; Rosenthal D
    Cancer Res; 1969 Mar; 29(3):571-8. PubMed ID: 5251290
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and cellular pharmacology of cytosine arabinoside.
    Kufe DW; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):34-48. PubMed ID: 3925560
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of cytosine arabinoside on human tumor cells isolated from malignant effusions: in vitro phosphorylation and inhibition of DNA synthesis.
    Stahel RA; Peter HJ; Sauter C
    Med Pediatr Oncol; 1979; 6(4):303-11. PubMed ID: 481320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients.
    Brox L; Mowles D; Belch A
    Eur J Cancer (1965); 1979 Oct; 15(10):1263-8. PubMed ID: 293261
    [No Abstract]   [Full Text] [Related]  

  • 12. Synchronization and recruitment in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders.
    Brach M; Stone R; Kufe D
    Biotechnol Ther; 1991; 2(3-4):269-83. PubMed ID: 1845130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.
    Heinemann V; Jehn U
    Leukemia; 1990 Nov; 4(11):790-6. PubMed ID: 2232893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of DNA synthesis in peripheral leukemic cells by cytosine-arabinoside; attempt at deriving therapeutic application].
    Schleusner A; Schütt M; Langen P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):218-25. PubMed ID: 6168530
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
    Sonis ST; Falcão R; MacLennan IC
    Br J Cancer; 1977 Sep; 36(3):307-12. PubMed ID: 270373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.
    Preisler HD; Epstein J; Raza A; Azarnia N; Browman G; Booker L; Goldberg J; Gottlieb A; Brennan J; Grunwald H
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1061-8. PubMed ID: 6540689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia.
    Abraham A; Devasia AJ; Varatharajan S; Karathedath S; Balasubramanian P; Mathews V
    Ann Hematol; 2015 May; 94(5):883-5. PubMed ID: 25391240
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells.
    Malec J; Kornacka L; Sawecka J
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):539-45. PubMed ID: 518260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia.
    Smyth JF; Robins AB; Leese CL
    Eur J Cancer (1965); 1976 Jul; 12(7):567-73. PubMed ID: 1066282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.